InstalabLoading...
InstalabLoading...
Your body depends on folate for two things it does constantly: making new cells and repairing DNA. Every time a cell divides, whether in your bone marrow, your gut lining, or a developing embryo, it needs folate to copy its genetic instructions accurately. When folate runs low, those instructions get garbled, and the consequences show up in your blood, your brain, and your cardiovascular system long before you feel sick.
What makes this vitamin unusual is how quickly a shortfall causes damage. Your body has no way to manufacture folate on its own. It must come from food or supplements. And because blood cells and gut cells turn over rapidly, they are the first to suffer. A test that catches a downward trend in your folate level gives you time to correct it before deficiency becomes a diagnosis.
Folate (vitamin B9) circulates in your blood primarily as 5-methyltetrahydrofolate, a form your cells use to shuttle single carbon atoms between molecules. That might sound abstract, but it drives three processes you cannot live without. First, folate supplies the raw materials for DNA synthesis, specifically the building blocks called purines and thymidine that make up every strand of DNA. Without enough folate, your cells cannot copy their DNA properly, and cell division stalls.
Second, folate is the key ingredient in recycling homocysteine, an amino acid that builds up in your blood when this recycling pathway stalls. High homocysteine damages blood vessel walls and raises your risk for heart attack and stroke. Third, folate helps your body produce SAM (S-adenosylmethionine), a molecule that acts like a master switch, adding chemical tags to DNA, proteins, and brain chemicals to regulate how they function. This is why low folate affects everything from mood to cancer risk.
The cardiovascular evidence for folate is large and consistent. In a study of 115,664 adults from the UK Biobank, people in the highest quarter of dietary folate intake had 12% lower risk of cardiovascular events and 26% lower risk of dying from cardiovascular disease compared to the lowest quarter, after adjusting for standard risk factors. A separate study of 1,605 coronary artery disease cases in China found that people with the highest serum folate had 25% lower odds of coronary disease than those with the lowest levels.
The stroke data is particularly striking. A meta-analysis pooling 21 randomized trials with over 115,000 participants found that folic acid supplementation reduced stroke risk by 10%. The benefit was larger in countries without mandatory grain fortification (17% reduction), and within that group, people without prior heart attack or stroke saw a 23% reduction. A separate meta-analysis of seven randomized trials found a 17% reduction in total cardiovascular disease with folic acid.
Several large studies link higher folate to longer survival. In a Japanese community study of 3,050 adults followed for about 10 years, people in the top third of serum folate had 39% lower risk of dying from any cause compared to the bottom third. An analysis of nearly 29,000 Americans from the National Health and Nutrition Examination Survey (NHANES) found that people with the lowest folate levels had 30% higher all-cause mortality, 33% higher cardiovascular mortality, and 47% higher cancer mortality.
There is an important nuance here. In a study of over 14,000 adults at high cardiovascular risk, the relationship between dietary folate intake and death followed a J-shaped curve: moderate intake was protective, but higher intakes and supplementation were not consistently beneficial. Moderate dietary folate intake was associated with lower cardiovascular and all-cause mortality compared to the lowest intake levels. But folic acid supplementation in this high-risk group was associated with 44% higher cardiovascular mortality and 28% higher all-cause mortality compared to matched non-supplementing participants.
A meta-analysis of 18 prospective studies covering over 931,000 participants found that each additional 100 micrograms of daily dietary folate was associated with a 3% lower risk of colorectal cancer and a 7% lower risk of colon cancer specifically. The protective effect was stronger in people who smoked, drank alcohol, or had higher BMI. In the Nurses' Health Study, which followed over 86,000 women for 36 years, higher folate intake 16 to 20 years before diagnosis was associated with 17% lower colorectal cancer risk.
The most dramatic finding came from a pre-fortification NHANES cohort of over 14,500 adults: those in the highest quarter of dietary folate had 88% lower colorectal cancer mortality compared to the lowest quarter. This long latency period, with protection building over one to two decades, reinforces why starting early matters.
About one in four people with folate deficiency develops neuropsychiatric symptoms, including depression, cognitive impairment, and in rare cases spinal cord problems, even without anemia or other blood abnormalities. Up to a third of psychiatric hospital admissions have been found to have low folate concentrations.
A study of 3,140 adults over age 50, followed for eight years, found that low baseline folate predicted faster cognitive decline. A meta-analysis combining 95 studies with over 46,000 participants found that higher dietary folate was associated with 39% lower risk of developing dementia. B vitamin supplementation for longer than 12 months produced measurable improvements in cognitive test scores, with the greatest benefits in people who did not yet have dementia.
The CARDIA study followed over 4,000 young adults for 30 years from their late teens into midlife. Compared to those with the lowest folate intake, those in the middle and upper ranges had 65% to 66% lower risk of developing chronic kidney disease. The relationship followed an L-shaped pattern: the biggest drop in risk came from moving out of the lowest intake range, with diminishing returns at very high intakes.
This is folate's most well-established preventive role. In a Norwegian study of nearly 900,000 births, women who took folic acid before and during pregnancy had about half the risk of neural tube defects compared to those who did not supplement. The US Preventive Services Task Force recommends 400 to 800 micrograms of folic acid daily for all people planning or capable of pregnancy, with higher doses (4,000 micrograms) for those with a prior affected pregnancy.
Your lab will report serum folate in ng/mL or nmol/L (to convert, multiply ng/mL by 2.266). Reference ranges vary between labs and assay methods, so the most reliable approach is to compare your results within the same lab over time. That said, published research supports the following interpretation tiers for serum folate.
| Tier | Serum Folate Range | What It Suggests |
|---|---|---|
| Deficient | Below 3 ng/mL (below 7 nmol/L) | True folate depletion. Increases risk for megaloblastic anemia (a condition where red blood cells become abnormally large and dysfunctional), elevated homocysteine, and neuropsychiatric symptoms. Retest while fasting and supplement promptly. |
| Low/Marginal | 3 to 6 ng/mL (7 to 14 nmol/L) | Negative folate balance. Tissue stores may be depleting. Investigate diet, medication use, and absorption. |
| Normal | 6 to 20 ng/mL (14 to 45 nmol/L) | Adequate for most functions. Aim for the upper half of this range if you have cardiovascular risk factors or are planning pregnancy. |
| Elevated | Above 20 ng/mL (above 45 nmol/L) | Usually reflects supplementation or fortified food intake. Not harmful in isolation, but check vitamin B12 status to rule out a dangerous imbalance. |
These tiers are drawn from published research. Your lab may use different assays and cutpoints. Compare your results within the same lab over time for the most meaningful trend. For women planning pregnancy, the target is a serum folate of at least 11.3 ng/mL (25.5 nmol/L), which corresponds to the red blood cell folate level associated with optimal neural tube defect prevention.
Differences exist across demographics. Non-Hispanic Black women have about 20% lower red blood cell folate than non-Hispanic white women in the US population. Younger women (ages 15 to 19) have roughly twice the odds of lower folate status compared to older women of childbearing age. Despite these differences, the same clinical cutpoints are used for everyone.
This is arguably the most clinically dangerous misunderstanding around folate. High folate combined with low vitamin B12 does not simply mask B12 deficiency by correcting the blood count. Emerging evidence suggests it may actively worsen the problem. People with low B12 and high folate have worse cognitive function, higher homocysteine, and higher methylmalonic acid (a specific marker of B12 deficiency) than those with low B12 and normal folate. The mechanism appears to involve excess folic acid depleting the active form of circulating B12, further starving tissues of this vitamin.
This means you should always check vitamin B12 alongside folate. If your folate is high (especially from supplements or fortified foods) and your B12 is low, the combination may be doing more harm than good.
Serum folate is a responsive marker, which means it reflects recent intake rather than deep body stores. That responsiveness makes it useful for tracking, but it also makes a single reading easy to misinterpret.
A single folate reading tells you what your level was on that particular day, influenced by what you ate in the prior 24 to 48 hours, whether you were fasting, and whether you were feeling well. That is useful, but limited. Serial measurements are where the real insight lives.
Your serum folate naturally fluctuates by about 10.7% from one draw to the next, even when nothing has changed. Because of this normal variation, two consecutive readings need to differ by at least 32% before you can be confident the change is real and not just normal biological fluctuation. If you are making dietary changes or starting a supplement, give it at least four to eight weeks before retesting, and always draw the sample fasting at a similar time of day.
A practical schedule: get a fasting baseline, retest in three to six months if you are making changes, then at least annually. If your level is in the deficient or low range, retest within four to six weeks after starting supplementation to confirm your body is absorbing it. People with kidney disease, malabsorption conditions, or on medications that deplete folate should track more frequently, roughly every three to six months.
Evidence-backed interventions that affect your Folate level
Vitamin B9 is best interpreted alongside these tests.